From protection to strategy: How HealthTech innovators can leverage IP

The fourth session of the EVOLVE2CARE Training Series for HealthTech Innovators and Researchers took place on 24 July 2025, bringing sharp focus to one of the most essential, and often overlooked, aspects of innovation: intellectual property (IP).

The session, titled “Unlocking IP Value – Protection, Collaboration & AI Innovations,” was led by Yannis Skoulikaris, Founder and Managing Director of PatentMind Netherlands BV, and former Director at the European Patent Office (EPO). PatentMind offers expert guidance based on deep knowledge of software patents, AI innovation, and international patent law.

What is Intellectual Property, and what does it protect?

The session outlined the four types of IP and what they protect:

1. Patents – Protect technical inventions and unique processes or products

Patentable examples include:

  • Algorithms, software methods, if embedded in a technical solution to a technical problem

2. Copyright – Protects code, content, and creative works

Patentable examples include:

  • Source code
  • Manuals
  • Graphics

3. Trademarks – Protect brands, logos and names

Used for:

  • Product names
  • Company logos

4. Trade secrets – Protect confidential information, algorithms and know-how

Includes:

  • Source more
  • Formulas
  • Client lists

The instructor highlighted that Intellectual Property is the secret weapon of innovators for protecting, managing, and unlocking value from their innovation.

Why does it matter?
  • Competitive advantage
  • Company Valuation & Investment
  • Licensing Opportunities
  • Legal defence & Risk mitigation

In the fast-evolving world of tech and AI, strong IP protection is crucial for staying ahead, attracting investors, and safeguarding innovation.

Patents in focus

Patents are one of the most powerful tools to protect and commercialize innovation—especially in HealthTech and AI-driven environments.

What can be patented?

To receive a patent, an idea must be novel and solve a real problem. The specific requirements vary slightly by region:

  • In Europe, the invention must provide a technical solution to a technical problem.
  • In the US, it must offer a useful solution to a practical problem.
Why do patents matter—particularly in tech and AI?
  • They protect your innovations from being copied by competitors.
  • They increase your company’s valuation and attractiveness to investors.
  • They create new licensing and collaboration opportunities.
  • Importantly, patent rights are granted to the applicant, not necessarily the inventor—making early filing and clear agreements essential.
How does the patenting process work?

The pathway from idea to protection follows a clear structure:

  • Search: First, check if your invention is new.
  • Application: File with the relevant patent office.
  • Search/Examination: Patent office reviews your application in an interactive process, involving the applicant.
  • Patent Granted
The power and peril of collaboration in IP

Collaboration is a cornerstone of innovation—but when it comes to Intellectual Property, shared ownership must be managed with clarity and care. Navigating shared IP ownership—whether with co-founders, collaborators, or licensees—requires balancing benefits and risks.

Why collaboration pays

Working with co-founders, collaborators, or licensees can accelerate development and expand your market reach. Benefits include:

  • Shared expertise and resources, fostering deeper innovation
  • Faster time-to-market through increased development capacity
  • Broader visibility via partner distribution and co-marketing channels

The risks without IP agreements

  • Ownership disputes – unclear title can derail projects
  • Usage conflicts – unauthorized use or overlapping commercialization
  • Enforcement issues or gridlock – difficult to license or defend jointly

Key takeaways

  • IP is a critical asset: Proactively identify, protect, and manage your intellectual property
  • Testing Innovation: Know which aspects of your work are eligible for protection
  • Collaboration: Always set clear IP agreements at the start of any partnership
  • AI’s unique IP challenge: Data, algorithms, and AI-generated works require tailored IP strategies
What’s next?

The next session in the EVOLVE2CARE Training Series for HealthTech Innovators and Researchers is titled “Fundraising & Pitching Strategies – An Investor’s Guide for Innovators.” It will feature Adriane Thrash, Managing Partner at Anthology Ventures, as the special speaker.

The session is scheduled to take place on 4 September 2025 at 15:00 CEST and will offer expert insights on how to craft compelling pitches and navigate the fundraising process with confidence. Designed for innovators looking to connect with investors and elevate their ventures, this event is a key opportunity to gain strategic guidance from an industry leader.

Stay tuned as we continue to bridge the gap between innovation and market with practical knowledge for real-world success.

Founder’s lens: Building sustainable HealthTech solutions

The third online session of the EVOLVE2CARE Training Series for Innovators and Researchers took place on 17 July 2025, offering a grounded and insightful look into the entrepreneurial path of a HealthTech founder. Titled “Building a Sustainable HealthTech Business – A Founder’s Journey,” the session was led by Panagiotis Katsaounis, Medical Geneticist and CEO of Metabio, a company pioneering IT solutions for biobanks. 

The session formed part of the six-part EVOLVE2CARE series From User to Market – Faster Validation and Commercialisation for HealthTech Innovators and Researchers, which supports HealthTech innovators working in Transitional Care and Clinical Pathways to accelerate their journey from research to real-world impact.

Why biosamples matter — and Why managing them is hard

Biosamples are a cornerstone of biomedical research and power medical R&D excellence, supporting advancements in diagnostics, drug discovery, genetics and environment.

However, IT systems to manage biosamples and associated data are often inadequate and problematic for researchers; unreliable, leading to poor data harmonization across sources; and limited, failing to capture the historical dimension of biosample usage. As a result, valuable data remains underutilized or inaccessible. 

This challenge laid the groundwork for the creation of Metabio, a next-generation IT platform designed to modernize and integrate the full spectrum of biosample data. By offering real-time access, harmonized metadata, and GDPR/HIPAA-compliant tools, Metabio enables biobanks, researchers and the entire research ecosystem to unlock the true potential of the biosample collections.

Key highlights

Identifying the real value

The instructor described how Metabio emerged from direct experience in the lab, where data quality gaps and outdated biobank IT systems conflicted with cost and time constraints.

Building the business model

Participants were guided through Metabio’s evolution from an idea to a revenue-generating SaaS platform. 

A breakdown of real startup costs revealed a balanced allocation:

  • 35% for team and operations
  • 30% for R&D and clinical validation
  • 20% for sales and marketing
  • 15% for regulatory compliance

This financial transparency highlighted the importance of lean spending, focused prioritization, and resource-efficient scaling.

Practical advice for HealthTech founders

Panagiotis Katsaounis shared several turning points, including a major shift from offering physical infrastructure to delivering modular, interoperable software. He emphasized that being responsive to market feedback and recognizing internal limitations were critical to navigating early-stage uncertainty.

The session closed with a set of key takeaways aimed at helping other innovators design more viable and resilient ventures:

  • Prioritize Speed and Iteration: Avoid over-engineering early on. Launch MVPs quickly rather than chasing perfection.
  • Cultivate deep customer and patient empathy: True innovation starts with understanding. Invest time in interviews, shadowing, and co-creation.
  • Build resilience and a supportive network: Surround yourself with a core team that shares the long-term vision. Replace doubt with determination.

What’s next

The upcoming session “Unlocking IP Value: Protection, Collaboration & AI” on Thursday 24 July, 2025, at 15:00 CEST, will explore how to protect intellectual assets, manage innovation in collaborative environments, and navigate new IP challenges in the age of artificial intelligence.

Stay with us as we continue to equip innovators with the tools to build, scale, and sustain meaningful healthtech solutions—from user to market.

Applying Service Design in Living Labs: Webinar highlights

The second session, titled “Designing Tailored Living Lab Services for Innovators”, which is part of the Living Labs Training Series, took place on 9 July 2025. It focused on designing structured, user-oriented services that enable Living Labs to better support innovators, accelerate experimentation, and ensure sustainable operations.

This six part training program is specifically crafted for Living Lab managers, researchers, and innovation professionals. It brings together top experts in service design and real-world practitioners from across Europe. The last webinar featured contributions from:

What is Service Design?

Francesca Sperandio opened the session by introducing the central question: “What is Service Design?” She explained that Service Design is about intentionally planning and organizing all the different touchpoints and interactions—from users and staff to platforms and operations—that collectively make up a service. 

  • Service Design is human-centered, evidence-based, and follows an iterative, collaborative process.
  • Living Labs, likewise, emphasize active user involvement, real-life experimentation, and co-creation.

Case Studies from the Thessaloniki Action for Health & Wellbeing Living Lab

In her turn, Despoina Petsani shared two concrete case studies from the Thessaloniki Action for Health & Wellbeing Living Lab, developed within the framework of the VITALISE project. VITALISE enables researchers from various disciplines to access European Living Lab infrastructures through Transnational Access.

These examples highlighted not only the innovative services developed—such as ASSURE, an AI tool for dysphagia detection, and HESTIA, a thermal monitoring system to support informal caregiving—but also the concrete resource needs involved in delivering them.

For each pilot, she presented a side-by-side comparison of time and personnel dedicated by internal and external teams. Internal refers to the Living Lab’s own staff, who are familiar with lab protocols, logistics, and stakeholder engagement, while external refers to visiting researchers granted access through the project.

The data showed needs for 170h/30d internal vs. 52h external for ASSURE project, and 121/28d internal vs. 14d external for HESTIA—demonstrating that effective Living Lab services require considerable coordination and time investment.

Structuring and Pricing Living Lab Services

Marta I. De Los Ríos White guided participants through a practical methodology for turning Living Lab activities into repeatable, well-defined services. 

The structured 5-step Servive Design Process included:

  1. Discover: the phase of immersion, where tools like interviews, observations, and self-documentation help capture real user needs and contextual insights.
  2. Define: a period of analysis—making sense of the findings, spotting patterns, and setting a clear design challenge.
  3. Develop: the creative core of the process, where ideas are generated, sketched, and prototyped through both visual and tactile methods.
  4. Deliver: this stage transforms ideas into action—pitching, role-playing, testing, gathering feedback, and capturing learnings.
  5. Evolve: a forward-looking stage focused on scaling, building partnerships, tracking impact, and celebrating even subtle change.

Do you know how to price your services?

To close, Marta I. De Los Ríos White presented three guiding steps for Living Labs ready to define the value of what they offer. First, she encouraged participants to assess the value their services provide to innovators, including the time saved, risk reduced, and unique benefits delivered. Next, she stressed the importance of understanding internal costs—factoring in people’s time and expertise, specialized tools, resources, and overhead. Finally, she highlighted the need to align pricing strategies with the Living Lab’s broader mission and funding model, ensuring financial sustainability while staying true to core objectives.

What’s next?

The next session for Living Labs, “Navigating Legal, Ethical & Regulatory Frameworks,” will take place on August 27, 2025, at 15:00 CEST, and will approach the ethical, legal and regulatory frameworks, explores the sector-specific compliance and engages with regulatory bodies.

Highlights from the 1st webinar for Living Labs

The first session of “Trainings on Service Design for Living Labs”, held on June 25, 2025, successfully brought together 23 participants for an engaging and insightful webinar titled “The Role of Living Labs in the Innovation Ecosystem.” The session featured five distinguished speakers—Prof. Dr. Dimitri Schuurman,  Senior Research Strategist (ENoLL), Ingrid Adriaensen, Business Manager (LiCalab), Dr. Eva Kehayia (RehabMaLL), Clara G. García Blanch, Pilot Test Manager, (Suara), and Sofía Ballesteros Rodríguez, Social Worker (Fundación INTRAS)—and was facilitated by Marta I. De Los Rios White and Francesca Sperandio from ENoLL.

The discussion began with Prof. Schuurman, who situated Living Labs within broader innovation frameworks, tracing their evolution from the Triple Helix model (government, academia, industry) to the more inclusive Quadruple Helix, which incorporates civil society. He emphasized the strategic role of Living Labs in open innovation, particularly their contributions to value creation, co-creation, and real-life experimentation. He also introduced a framework for navigating complexity across strategic, tactical, and operational levels.

Building on this, he described the importance of anchoring Living Labs in a clear mission and vision—one that addresses long-term partnerships, user needs, and value creation—through an ecosystem-driven approach. Finally, he illustrated how Living Labs function in practice across three layers: multi-actor orchestration at the organizational level, multi-method and real-life experimentation at the project level, and active stakeholder engagement through co-creation and co-design at the activity level—underscoring their dual role in fostering open innovation and empowering user innovation.

Following this, each speaker presented a unique Living Lab case, offering practical insights into how these collaborative environments are driving user-centered innovation across diverse sectors.

Ingrid Adriaensen – LiCalab

Ingrid Adriaensen presented the Living and Care Lab (LiCalab) based in the Province of Antwerp, Belgium, embedded within Thomas More University of Applied Sciences. She explained how LiCalab supports companies in developing and validating care-related innovations by offering a strong user research infrastructure, including a panel of over 1,200 citizens and care professionals, and by leveraging collaborations with hospitals, municipalities, and international networks.

LiCalab focuses on care technology—including e-health, medtech, assistive and communication tools—and innovative models for collaboration in care settings, with a strong emphasis on sustainability, inclusion, and both digital and health literacy. A key example was the ‘Welgerust’ (Well Rested) project, a multi-actor initiative tackling sleep issues through a blended care approach. The solution combines the Moonbird device—which uses biofeedback to guide users through optimal breathing patterns—and tailored psychological support. The project, which targets both adults and children, caregivers, and a local hospital, illustrates how Living Labs can drive user-centered innovation from early-stage development to real-world testing.

 

Dr. Eva Kehayia – RehabMaLL

Dr. Eva Kehayia (CRIR – Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal) presented the Rehabilitation Living Lab (RehabMaLL), a pioneering initiative promoting full social participation and inclusion for people with disabilities. Situated in a public commercial mall in downtown Montreal, RehabMaLL offers a real-life environment where citizens, researchers, clinicians, policy makers, and community organizations come together to co-design and test socially inclusive innovations. Eva showcased the TeleRehab-GT platform, developed collaboratively with stroke survivors, caregivers, and health professionals to ensure that telerehabilitation tools align with users’ needs and values. The Living Lab fosters innovation through inclusive, interdisciplinary collaboration, combining real-world conditions with simulation spaces, and guided by the core principles of respect, equity, and user empowerment.

The RehabMaLL is a multi-tasking environment that enables users to engage in everyday activities (e.g., shopping, and social interaction) while testing assistive or rehabilitative technologies. This setup allows researchers to evaluate user experiences in dynamic, real-life contexts, increasing the relevance and applicability of innovation outcomes.

Clara G. García Blanch – Suara Social Digital Living Lab

Clara García Blanch presented the work of Suara’s Social Digital Living Lab, which promotes technological and service innovation within one of Spain’s largest social economy cooperatives. The Living Lab is grounded in four core values: a person-centered approach to care and innovation, digital inclusion as a means to reduce inequalities, co-creation with all stakeholders from the outset, and a strong commitment to continuous evaluation, learning, and adaptation.

She explained that Suara delivers a wide range of services tailored to individual needs across the life course—from early childhood to elderly care, including areas such as functional diversity, social inclusion, adult education, and justice.

A key focus of her presentation was the collaboration with Broomx, an immersive technology company. Through this partnership, Suara implements immersive and virtual reality experiences for mindfulness, cognitive stimulation, and recreational purposes in care settings. These interventions support core areas such as well-being, neurorehabilitation, and psychostimulation, particularly benefiting vulnerable or older populations.

Sofía Ballesteros Rodríguez – MINDLab

Sofía Ballesteros presented the work of Fundación INTRAS, a non-profit organisation dedicated to supporting people with mental health conditions, cognitive impairments, and other vulnerabilities. At the core of INTRAS’ innovation strategy is MINDLab, its certified Living Lab and a member of ENoLL. MINDLab acts as a permanent co-creation space supporting innovators through close collaboration with users and professionals. Its intervention scope centres on people with mental health challenges and cognitive decline, and its main competencies include:

  • Cognitive intervention & rehabilitation through new technologies
  • Sensory Stimulation
  • Digital Health
  • Empowering personalized interventions
  • Co-design with users and public involvement
  • Dissemination, knowledge transfer & research networking
  • Digital learning, inclusion, and accessibility
  • Connected Care at home and Independent living solutions

Also, she introduced VIVEMAIS, a cross-border and transdisciplinary initiative funded by the European Union, which aims to promote the design, adoption, and use of assistive technologies (ATs). These technologies are essential tools that enhance the functional capabilities of individuals facing challenges in communication, mobility, memory, and learning.

The session set a solid foundation for the series, sparking meaningful dialogue and offering actionable insights for Living Labs committed to advancing user-centered innovation.

What’s next?

The next session for Living Labs, “Designing Tailored Living Lab Services for Innovators,” will take place on July 9, 2025, at 15:00 CEST, and will introduce service design principles while exploring how Living Labs can create customized services to better support innovators and their specific needs.

Webinar on HealthTech impact with Design Thinking & Living Labs

On June 19, 2025, the EVOLVE2CARE Training Series for HealthTech Innovators and Researchers continued with its second session, gathering over 20 participants for an engaging webinar on “Design Thinking in Action — A Living Lab Approach to HealthTech Innovation.” The session was led by Ioannis Poultourtzidis, Coordinator of the ThessAHALL Living Lab, a pioneering hub for health and wellbeing innovation, driven by the AUTH Lab of Medical Physics and Digital Innovation based in Northern Greece since 2014.

This insightful session offered a practical look at how Living Labs, when combined with Design Thinking, can empower researchers and innovators to build HealthTech solutions that are ethical, inclusive, and truly responsive to user needs. It addressed one of the core challenges in health innovation: too many technologies are developed without real-world validation. Living Labs help address this challenge by involving real users in real contexts, enabling co-creation and testing that lead to more relevant and usable solutions.

The 3-Step framework for impactful HealthTech innovation

At the core of the session was a practical 3-step framework developed to accelerate HealthTech solutions:

  • Understand

Innovation begins with an in-depth exploration of user needs, challenges, and environments. This phase involves stakeholder mapping, needs assessment, and early framing of design hypotheses. Living Labs enable immersion into users’ real-life settings — homes, clinics, and communities — without artificial filters. Special attention is given to capturing gender-sensitive and inclusive insights, ensuring solutions reflect the full diversity of users.

  • Engage

This step focuses on co-creation with all relevant stakeholders — patients, caregivers, clinicians, policy-makers, insurers, and technologists. Rather than gathering feedback after development, Living Labs bring stakeholders into the design process itself through co-design workshops, design sprints, and digital collaboration platforms. This inclusive, participatory model ensures that the solutions developed are relevant, feasible, and widely accepted. Innovation thrives on collaboration!

  • Build for impact

The final step emphasizes rapid prototyping, real-world testing, and iteration. Living Labs allow innovators to trial functional prototypes directly with users in authentic environments. This accelerates learning, reduces development risks, and ensures technical and business feasibility. The process supports agile development by turning insights into measurable outcomes, such as improved health, increased usability, and meaningful adoption

Innovation journey – 4 Phases

Living Lab Networks guide innovators through each of the four phases: design, technology, business, and impact.

Design: Human-centered design frames the solution based on desirability and real needs

Technology: Prototypes are tested for technical feasibility within Living Lab environments

Business: Viable business models are validated, considering cost, sustainability, and market fit

Impact: Solutions are evaluated on outcomes such as improved patient care, usability, and long-term value

This journey ensures that innovation is not just about new technology, but about developing sustainable, scalable solutions that create measurable value for healthcare systems and the people they serve.

Why Living Labs matter in HealthTech?

Living Labs offer a unique environment to design with, not just for, users by:

  • Providing access to diverse populations in natural settings
  • Capturing real-time feedback and behavioral insights
  • Helping de-risk innovation by validating usability and integration early
  • Supporting ethical, GDPR-compliant, and inclusive research practices

What’s next in the EVOLVE2CARE training sessions series for HealthTech Innovators and Researchers?

The next session in the series, “Building a Sustainable HealthTech Business – A Founder’s Journey,” will take place on July 17, 2025, at 15:00 CEST. Participants will have the opportunity to hear from Panagiotis Katsaounis, CEO of Metabio, as he shares the real-world story of growing a HealthTech startup from idea to validated solution. The session will explore key business decisions, unexpected challenges, and the strategic pivots that shaped the company’s journey, offering a grounded look into the entrepreneurial side of healthcare innovation.

First webinar on supercharging innovation with LLMs & No-Code Tools

On June 12, 2025, the EVOLVE2CARE project successfully kicked off the first session of its Training Series for HealthTech Innovators and Researchers titled “From Users to Market – Faster Validation and Commercialisation for HealthTech Innovators and Researchers”, introducing participants to cutting-edge strategies for accelerating innovation through Large Language Models (LLMs) and No-Code platforms for rapid prototyping.

Led by Metaxas Gamvrelis, Technical & Training Lead at Anthology Ventures, the session “Accelerating Innovation — Leveraging LLMs & No-Code for Rapid Prototyping” brought together over 15 healthcare innovators and researchers, and offered a practical and inspiring deep dive into how tools and No-Code platforms like ChatGPT, Landbot, Lovable, and Google Gemini can dramatically shorten the innovation lifecycle—from early ideation to real-world deployment.

Rethinking prototyping: From weeks to days

Metaxas Gamvrelis opened the session by contrasting the traditional approach to prototyping—often slow, costly, and resource-intensive—with today’s possibilities enabled by AI and automation. He introduced a streamlined 4-stage framework that demonstrated how LLMs and No-Code tools transform each step:

Stage 1: Idea to Prototype

AI-LLMs can accelerate product ideation and planning by:

  • Brainstorming product features and user stories
  • Drafting Product Requirement Documents (PRDs)
  • Generating user personas & customer journey maps
  • Summarizing market research

Stage 2: User testing

Feedback is fuel for innovation. With AI-powered support, innovators can:

  • Set up user tests quickly and with minimal resources
  • Gather diverse feedback from surveys, interviews, and chatbots
  • Perform initial analysis of results to identify key insights fast
  • Perform sentiment analysis and theme extraction

Stage 3: Iterate & Improve

Once initial feedback is collected, the real power of LLMs and No-Code tools emerges, enabling rapid iteration, continuous refinement, and smarter decision-making without starting from scratch.

  • LLMs help extract insights from user feedback, generate improvement suggestions, and update designs/requirements in real time.
  • Tools like Lovable and Figma support versioning and A/B testing, making iteration cycles faster, smarter, and more agile.

Stage 4: Deploy Rollout (MVP)

With minimal development time, MVPs can be launched using No-Code platforms such as Glide, Replit, and Retool.

LLMs assist by:

  • Generating product documentation
  • Drafting marketing copy, landing pages, FAQs
  • Creating onboarding flows (emails, chatbot scripts)
  • Even code snippets for future integrations

Living Labs reimagined: More agile than ever

In the next part of the session, the training and technical expert explored how this tech revolution aligns perfectly with the Living Lab methodology, a cornerstone of EVOLVE2CARE project. By combining co-creation, iteration, and real-life user involvement with the agility of LLMs and No-Code:

  • Prototypes can be created on-demand during co-design sprints
  • Feedback can be gathered in real-time through smart forms and bots
  • Iteration becomes virtually limitless within project timelines

“Living Labs are a huge gift,” he said, “because they help people check services before they’re fully developed. And now, they can do it faster, with less risk.”

To close the session, Metaxas Gamvrelis walked participants through real-time examples of how he uses ChatGPT in his own workflow. He emphasized the value of clear, well-structured prompts and shared one of his go-to techniques: “At the end of each prompt, I always ask: ‘Do you understand the task?’—it’s a small step that ensures accuracy. 

What’s next?

This first session set the tone for EVOLVE2CARE’s Training Series—equipping HealthTech innovators and researchers with practical tools to accelerate early-stage development using LLMs and No-Code platforms. The second session, “Design Thinking in Action — A Living Lab Approach to Healthtech Innovation,” is scheduled for Thursday, 19 June 2025 at 15:00 CEST.

Join us as we dive into the power of design thinking in real-life healthcare contexts. Led by Ioannis Poultourtzidis, Coordinator of the ThessAHALL Living Lab, the session will explore how co-creation, inclusivity, and user-centered design lead to more relevant, ethical, and effective innovations.

EVOLVE2CARE at the 1st Morning Health Talk in Athens

On June 2, 2025, EVOLVE2CARE was proudly represented at the 1st Morning Health Talk – Greece, held at the National Documentation Centre in Athens. The event was organized by EIT Health Greece under the theme: “Co-Creating Health Innovation Ecosystems: Empowering Providers and Citizens Beyond Financial Incentives.

Evdokimos Konstantinidis, Project Coordinator of EVOLVE2CARE (AUTH Medical Physics & Digital Innovation Lab), delivered a talk highlighting the role of Living Labs in advancing healthcare innovation. His presentation focused on how Living Labs can drive healthcare innovation by supporting care transitions, empowering caregivers, and enabling real-world clinical research through open, co-creative ecosystems.

The event brought together digital health experts, care providers, researchers, and policymakers, fostering dialogue around inclusive, user-driven innovation in healthcare.

EVOLVE2CARE’s presence at the event reinforced its mission to foster co-creation and user-driven innovation in Transitional Care, underscoring the role of Living Labs in advancing healthcare innovation.

Training programs to support Innovators & Living Labs

Building on EVOLVE2CARE’s ongoing commitment to fostering collaboration between innovators and Living Labs, we are excited to announce the launch of two tailored training programs. The former program targets HealthTech innovators and researchers, equipping them with the necessary tools and knowledge to successfully commercialize their research and bring innovations to market. The latter is specifically designed for Living Labs, aiming to enhance their capacity to support innovators and strengthen their role in the development and testing of HealthTech solutions.

As the Open Call is actively inviting HealthTech innovators and Living Labs to collaborate on innovative solutions for Transitional Care (Task 2.2 – LLs, Innovators, and Researchers Scouting and Selection), EVOLVE2CARE is taking the next step by offering educational support. Through Task 2.3 – Training Program for Living Labs and Task 2.4 – Training Program for Innovators and Researchers, we are ensuring that both innovators and Living Labs are well-prepared for successful collaboration.

Training Program for Innovators and Researchers (T2.4)

This six-part Training Program, named “From Users to Market – Faster Validation and Commercialisation for HealthTech Innovators and Researchers” and leb by Anthology Ventures, will give innovators and researchers the tools, skills, and mindset needed to navigate the complex journey from lab to market.

Each session builds practical know-how in agile innovation, systems thinking, and stakeholder collaboration—while real startup founders share insights on fundraising and commercialization. Whether you’re prototyping, pitching, or scaling, this program guides your journey to real-world impact.

This program is ideal for researchers, early-stage innovators, and knowledge transfer professionals seeking to accelerate the journey from health tech research to real-world impact.

1️⃣Accelerating Innovation — Leveraging LLMs & No-Code for Rapid Prototyping | 12 June, 2025 | ️15:00 CEST

Description: This session explores how large language models (LLMs) and No-Code platforms are revolutionizing early-stage innovation. Participants will learn how to quickly transform ideas into interactive prototypes, generate user personas, draft product requirements, and create testable concepts without writing a single line of code.

2️⃣Design Thinking in Action — A Living Lab Approach to Healthtech Innovation |19 June, 2025 | 15:00 CEST

Description: This session explores how large language models (LLMs) and No-Code platforms are revolutionizing early-stage innovation. Participants will learn how to quickly transform ideas into interactive prototypes, generate user personas, draft product requirements, and create testable concepts without writing a single line of code.

3️⃣Building a Sustainable HealthTech Business — A Founder’s Journey | 17 July, 2025 | ️ 15:00 CEST

Description: In this session, participants will hear directly from a founder who turned a bold idea into a validated, mission-driven business. This session goes beyond theory to offer an honest look at the business model decisions, revenue hurdles, cost surprises, and strategic pivots that shaped their journey.

4️⃣Unlocking IP Value — Protection, Collaboration & AI Innovations | 24 July, 2025 |15:00 CEST

Description: This session breaks down the core types of IP (patents, copyrights, trademarks, trade secrets) with a special focus on HealthTech and AI-driven innovation. Participants will learn how to identify what aspects of their product are protectable, how to avoid common pitfalls, and how to turn their IP strategy into a competitive advantage.

5️⃣Fundraising & Pitching Strategies — An Investor’s Guide for Innovators | 4 September, 2025 | 15:00 CEST

Description: In this session, a managing partner from Anthology Ventures will walk the participants through how to build a funding strategy that aligns with their goals, stage of development, and long-term vision. They will learn how to identify which investor types—angel, VC, corporate, or impact—are right for them, and how to approach them with clarity and confidence.

6️⃣Measuring Impact & Scaling Pilots — Driving Evidence-Based Growth in Living Labs | 19 September, 2025 | 15:00 CEST

Description: In this final session, we explore how innovators can measure meaningful outcomes, not just outputs, and use data to drive sustainable growth. Participants will learn how to define success through SMART metrics, design robust pilot evaluations, and generate the evidence that funders, policymakers, and partners look for.

EVOLVE2CARE encourages all interested stakeholders to take advantage of these opportunities to enhance collaboration and strengthen innovation in the healthcare sector.

Training Program for Living Labs (Task 2.3)

This six-part training program, named “Trainings on Service Design for Living Labs” and led by European Network of Living Labs (ENoLL), will provide participants with the tools and knowledge to support innovators in evaluating experimental outcomes and commercializing research effectively.

By adopting a structured, service design-based approach, you will learn to develop sustainable services, navigate legal and ethical challenges, and enhance stakeholder engagement. Ultimately, this will ensure a smoother transition from research to the market.

These sessions are designed for Living Lab managers and coordinators, researchers, innovators, teams establishing new Living Labs, technology transfer professionals, and policymakers involved in innovation ecosystems.

Topics per session:

1️⃣ The Role of Living Labs in the Innovation Ecosystem | June 25, 2025 |15:00 CEST

Description: This session provides an overview of the current innovation ecosystem and examines the strategic role of Living Labs in driving open innovation. It will highlight Living Labs’ contribution to societal and economic growth.

2️⃣ Designing Tailored Living Lab Services for Innovators | July 9, 2025 | 15:00 CEST

Description: This session introduces service design and explores the process of creating tailored services within Living Labs to effectively support innovators and their specific needs.

3️⃣ Navigating Legal, Ethical & Regulatory Frameworks | August 27, 2025 | 15:00 CEST

Description: This session approaches the ethical, legal and regulatory frameworks, explores the sector-specific compliance and engages with regulatory bodies.

4️⃣ Building Innovation Networks: Communication and Engagement | September 3, 2025 | 15:00 CEST

Description: This session focuses on the importance of building strong innovation networks and effective stakeholder engagement within Living Labs. Participants will learn how to engage stakeholders in service design, with a particular focus on the AccelUp platform.

5️⃣ Certification & Standardization of Living Labs | September 10, 2025 | 15:00 CEST

Description: This session explores the essential requirements for a Living Lab to achieve certification. Participants will learn about the benefits of certification, and international recognition.

6️⃣ Measuring Impact & Evaluating Success | September 24, 2025 | 15:00 CEST

Description: This session focuses on identifying key performance indicators (KPIs) to track the performance of Living Lab services. Participants will explore methods to evaluate service design and measure its impact and performance.

EVOLVE2CARE at Cluj Innovation Days 2025

On May 29, 2025, Vassilis Voulgarakis from ViLabs represented the EVOLVE2CARE project at Cluj Innovation Days 2025, held at Babeș-Bolyai University (BBU) in Cluj-Napoca, Romania. This flagship annual event, under the theme “Transforming Healthcare through Technology: Ethical, Human-Centric, and AI-Driven Solutions,” focused on digital transformation in the MedTech sector.

As a speaker in the panel “Bridging Research, Technology, and Healthcare,” Vassilis discussed the importance of interdisciplinary collaboration in creating patient-centric, tech-enabled healthcare solutions. In addition to his speech, Vassilis gave an interview to local media, to explain how EVOLVE2CARE is looking to foster new collaboration opportunities for HealthTech innovation across Europe, bringing together researchers, startups, and innovators with Living Labs.

Vassilis also engaged in seven targeted B2B matchmaking meetings, where he presented the EVOLVE2CARE Open Call opportunity to startups and innovators. The matchmaking sessions, also, provided a platform to meet with startups, innovators, and fellow project managers, discussing potential synergies and knowledge exchange opportunities relevant to our project’s objective.

EVOLVE2CARE x GILL: Expanding our gender-informed policy

Following our insightful mini-webinar in March 2025, EVOLVE2CARE is excited to highlight the next phase of the collaboration with the GILL – Gendered Innovation Living Labs, a Horizon Europe project. This time, we extended our efforts to the entire GILL consortium during their 5th consortium meeting, held on May 22, 2025.

This in-person meeting, focused on the final stages of the GILL project and its overall impact, allowed EVOLVE2CARE, represented by Konstantina Tsimpita from AUTH Medical Physics & Digital Innovation Lab, to join forces with GILL’s gender innovation experts in advancing a comprehensive Key Performance Indicators (KPI) framework to support gender-responsive innovation in healthcare, entrepreneurship, and innovation ecosystems.

A central topic of discussion was the expansion of the societal key indicators framework, focusing on key axes such as:

  • Gender-balanced participation
  • Inclusive co-creation and decision-making
  • Gender-aware design of solutions
  • Gender-sensitive impact evaluation

These KPIs aim to embed gender perspectives throughout the innovation lifecycle and healthcare development, helping to ensure that outcomes are not only effective but also equitable and socially responsive.